Vaccination Completion Rate in the 75% Range... Over 16,000 Vaccinated on First Day for Ages 12-15

Photo by Yonhap News

[Asia Economy Reporter Moon Hyewon] As COVID-19 vaccination progresses smoothly in South Korea, the vaccination completion rate reached the 75% range as of midnight on the 2nd.

According to the COVID-19 Vaccination Response Promotion Team, the total number of people who have completed vaccination by receiving all recommended doses of the COVID-19 vaccine was 38,804,722 as of midnight on the day.

The vaccination completion rate is 75.6% compared to the population of South Korea (51,349,116 as of last December) and 87.9% compared to the population aged 18 and over.

The number of newly completed vaccinations, which had decreased to 20,354 due to the holiday effect on the 31st of last month, significantly increased to 118,436 the day before.

Breaking down the number of newly completed vaccinations by vaccine type the day before: Moderna 65,670, Pfizer 50,448, AstraZeneca (AZ) 1,738, and the rest were Janssen recipients.

By age group, the vaccination completion rate is highest among those in their 60s at 93.6%, followed by those in their 50s (92.9%), 70s (92.3%), and 80 and above (81.7%).

In the relatively late-starting young and middle-aged groups, the vaccination rate has rapidly increased, with those in their 40s at 86.6%, ages 18?29 at 83.5%, and those in their 30s at 81.5%. Those aged 17 and under are at 0.6%.

First-dose vaccinations also continued, with 82,747 people newly vaccinated the day before.

Among those aged 16?17, who have been receiving vaccinations since the 18th of last month, 409,580 had been vaccinated as of midnight on the day, and the cumulative number of pregnant women receiving the first dose increased to 1,196.

Among those aged 12?15, who started vaccination the day before, a total of 16,386 received their first dose. 27.8% (518,034) of the target group aged 12?15 have made reservations, and vaccination reservations will close on the 12th of this month.

The cumulative number of first-dose recipients is 41,224,561, which is about 80.3% of the population, and reaches 92.3% when based on the population aged 18 and over.

This content was produced with the assistance of AI translation services.